S2Medical AB (publ) OMXSTO:S2M:
SAID ON MONDAY EYRACURE, IN WHICH CO OWNS 22.3% OF SHARES, HAD FILED FOR BANKRUPTCY
CO'S HOLDING WAS PREVIOUSLY WRITTEN DOWN IN ITS ENTIRETY TO SEK 0 IN CONNECTION WITH FINANCIAL STATEMENTS FOR 2025
BANKRUPTCY HAS NO FURTHER IMPACT ON CO'S BALANCE SHEET, RESULTS, EQUITY OR CASH FLOW
Source text for Workspace:
Further company coverage: